ABEO (STOCKS)
Abeona Therapeutics Inc. Common Stock
$5.010000
-0.110000 (-2.15%)
Prev close: $5.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vishwas Seshadri
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $273.94M
- Employees
- 136
- P/E (TTM)
- 4.34
- P/B (TTM)
- 1.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $400.00K |
| Nonoperating Income/Loss | $1.02M |
| Operating Expenses | $83.61M |
| Depreciation and Amortization | $2.20M |
| Research and Development | $29.09M |
| Operating Income/Loss | -$83.21M |
| Income/Loss From Continuing Operations After Tax | $82.37M |
| Income/Loss From Continuing Operations Before Tax | $82.67M |
| Interest Expense, Operating | $3.94M |
| Net Income/Loss | $82.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $82.35M |
| Net Income/Loss Available To Common Stockholders, Basic | $82.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$34.00K |
| Preferred Stock Dividends And Other Adjustments | -$34.00K |
| Basic Earnings Per Share | $1.65 |
| Diluted Earnings Per Share | $1.21 |
| Basic Average Shares | 159,089,751 |
| Diluted Average Shares | 68,324,583 |
| Assets | $231.10M |
| Current Assets | $216.13M |
| Noncurrent Assets | $14.97M |
| Fixed Assets | $10.34M |
| Other Non-current Assets | $4.63M |
| Liabilities | $59.86M |
| Current Liabilities | $22.18M |
| Accounts Payable | $5.93M |
| Other Current Liabilities | $16.25M |
| Noncurrent Liabilities | $37.68M |
| Long-term Debt | $19.75M |
| Other Non-current Liabilities | $17.93M |
| Equity | $171.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $171.23M |
| Liabilities And Equity | $231.10M |
| Net Cash Flow From Operating Activities | -$74.93M |
| Net Cash Flow From Operating Activities, Continuing | -$74.93M |
| Net Cash Flow From Investing Activities | $114.35M |
| Net Cash Flow From Investing Activities, Continuing | $114.35M |
| Net Cash Flow From Financing Activities | $27.74M |
| Net Cash Flow From Financing Activities, Continuing | $27.74M |
| Net Cash Flow | $67.16M |
| Net Cash Flow, Continuing | $67.16M |
| Comprehensive Income/Loss | $82.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $82.44M |
| Other Comprehensive Income/Loss | $94.00K |